Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03958331 · ClinicalTrials.gov registry record · NA
Behavioral Economics and Adherence in Teens (BEAT!)
A NA study of Epilepsy and Adherence, Medication, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT03958331: Completed NA study of Epilepsy and Adherence, Medication, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT03958331 is a NA study of Epilepsy and Adherence, Medication that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 104 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03958331, a NA study of Epilepsy and Adherence, Medication, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
Non-adherence to antiepileptic drug therapy is a significant problem for adolescents with epilepsy and has a critical impact on health and patient-reported outcomes. Evidence-based adherence interventions are lacking in this population and are critically needed. This proposal seeks to develop and evaluate a mHealth social norms adherence intervention for adolescents with epilepsy.
Primary Outcome
A total mean adherence rates will be calculated based on daily adherence rates captured through the SimpleMed Pillboxes or AdhereTech bottles. Scores range from 0-100%, with higher scores representing better adherence.
Conditions Studied
Interventions
- BEHAVIORAL Individualized Adherence Feedback Report
- BEHAVIORAL Automated Digital Reminders
- BEHAVIORAL Individual Adherence Feedback Report with Social Norms
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2021-08-16 |
| Phase | NA |
What the finished NCT03958331 record still lists
NCT03958331 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Epilepsy appearing as the primary indexed condition, and to 3 interventions - of which Individualized Adherence Feedback Report is the first listed.
NCT03958331 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03958331 about?
NCT03958331 is a clinical study titled "Behavioral Economics and Adherence in Teens (BEAT!)". Non-adherence to antiepileptic drug therapy is a significant problem for adolescents with epilepsy and has a critical impact on health and patient-reported outcomes. Evidence-based adherence interventions are lacking in this population and are critically needed. This proposal seeks to develop and ev...
What is the current status of trial NCT03958331?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2019-09-01. Estimated completion is 2021-08-16.
What conditions does trial NCT03958331 study?
This clinical trial studies the following conditions: Epilepsy, Adherence, Medication.
What interventions are being tested in trial NCT03958331?
The interventions under investigation include: Individualized Adherence Feedback Report (BEHAVIORAL), Automated Digital Reminders (BEHAVIORAL), Individual Adherence Feedback Report with Social Norms (BEHAVIORAL).
Who is sponsoring clinical trial NCT03958331?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03958331 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03958331's enrollment target sits among peer trials
104 52nd of 160 higher than 109 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SeizEAR Safety Study
RECRUITING · NA
-
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
RECRUITING · NA
-
Subcortical Arousal in Perceptual Awareness
RECRUITING · NA
-
Prediction of Anxiety and Memory State
RECRUITING · NA
-
Implementation and Cost Evaluation of Project UPLIFT
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI